Cancer News
Submitted by admin on Fri, 06/14/2019 - 07:10
Dr. Zhen-Quan Xu Young Chinese Oncologist Training Fund is established by the children of the late Dr. Zhen-Quan Xu in 2017 in memory of their father, a highly respected Gastroenterologist and a Professor of Internal Medicine at the Shandong Medical University, Shandong, China.
Submitted by admin on Mon, 06/26/2017 - 20:48
We are pleased to announce that the 2016 Impact Factor (IF) of Chinese Journal of Cancer (CJC) is 4.111 according to the Journal Citation Reports released by the Clarivate Analytics on June 14, 2017.
Submitted by admin on Mon, 12/12/2016 - 12:49
在刚刚闭幕的IASLC WCLC 2016上，靶向药物无疑再次捍卫了其在晚期非小细胞肺癌（NSCLC）治疗领域的“明星”地位。新型靶点的探索，传统药物新治疗领域的拓展，液体检测在靶向药物疗效预测中的价值等研究，纷纷登录主席专场、口头报告、壁报等各种展示环节。
12月7日，在“靶向治疗新策略”口头报告环节发布的一项“突变选择性EGFR抑制剂AC0010（艾维替尼）在EGRF T790M非小细胞肺癌患者中的I、II期研究”，因其使用中国首个原创三代EGFR-TKI药物而备受关注。
Submitted by admin on Mon, 12/12/2016 - 12:49
本报讯 12月1日，由广东省抗癌协会、中国抗癌协会肿瘤靶向治疗专业委员会、美中抗癌协会、中山大学肿瘤防治中心、《癌症》杂志共同主办的“第五届广州国际肿瘤学会议暨第一届中国抗癌协会肿瘤靶向治疗专业委员会年会”在绿意盎然的羊城广州召开。
经历既往4届会议的铺垫与积累，“关注学科发展前沿，加强国内外学术交流”已经成为广州国际肿瘤学会议的主旨。本次为期3天的会议，邀请多名中外院士、200余位国内外肿瘤专家出席、参会演讲；通过全体大会、国际专场、学术报告，壁报讨论等环节，为2000余位从事肿瘤学研究和防治相关工作的参会学者，提供展示、学习和交流的平台。
Submitted by admin on Wed, 11/30/2016 - 10:34
Application Guidelines Asian Fund for Cancer Research
Funding Period: April 1, 2017 – March 31, 2019 October, 2016
Submitted by admin on Tue, 11/01/2016 - 13:07
2016年10月15-16日，由中国肿瘤防治联盟浙江省联盟筹委会与浙江省肿瘤靶向治疗技术指导中心筹委会共同主办，美中抗癌协会（USCACA）协办的中国肿瘤防治联盟浙江省联盟暨浙江省肿瘤靶向治疗技术指导中心成立大会，在浙江杭州邵逸夫医院下沙院区圆满召开。近200位顶级肿瘤专科专家参会。作为专注于管理中美肿瘤治疗资源的移动智慧医疗服务平台，美尊医询全程助力大会召开，连接美方高端专家资源，提升中美医学交流水平！
行业聚焦：打造中美肿瘤医疗连接平台的呼声
Submitted by admin on Mon, 09/19/2016 - 10:41
Dr. George Wilding, a Board Member of USCACA and the Vice Provost of MD Anderson Cancer Center, led a delegation to attend the 2nd International Conference on Translational Cancer Research held in Tianjin during August 2016. Dr. Wilding and Dr. Ping Wang, the President of Tianjin Medical University Cancer Hospital and Institute, also signed an Agreement to continue the Sister Institute Relationship for 5 additional years after 10 years’ highly successful partnership.
Submitted by admin on Sun, 09/18/2016 - 17:34
USCACA is an endorser of the World Precision Medicine Summit 2016 to be held in Shanghai during December 3-4. Dr.Wei Zhang will serve as a moderator and panel discussant.USCACA friend, the Director of Wake Forest Cancer Center, Dr. Boris Pasche will deliver a keynote speech on precision oncology initiative at Wake Forest.
Pages
